Innate Pharma seeks to follow best practice in corporate
governance.
The company set up a Scientific Advisory Board in 2000, a Compensation Committee in 2001 and an Audit Committee
in 2003.
In May 2025, Innate Pharma was transformed into a SA with a Board of Directors.
The Board of Directors is responsible for defining the Company's strategy. Its members have significant experience in the biopharmaceutical sector.
Governance Committees
To date, the Supervisory Board has four sub-committees:
- the compensation and nomination committee,
- the audit and Sustainability committee,
- the transaction committee,
- the R&D committee.
All four committees report to the Board of Directors.